TLR7/8A（TLR7/8 Agonist）and OX40A（OX40 agonist antibody）can synergize for enhanced anti-tumor immunity。
TLR7/8 agonist activates TLR7/8 pathway, prompt the maturation of DC cells, strengthens the presentation of neoantigen of tumor cells or the viral antigen to T cells, boost the anti-tumor/antiviral immunity
